[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

AU726094B2 - Acetylsalicylic acid-containing transdermal therapeutic system with absorption enhancement - Google Patents

Acetylsalicylic acid-containing transdermal therapeutic system with absorption enhancement Download PDF

Info

Publication number
AU726094B2
AU726094B2 AU59862/98A AU5986298A AU726094B2 AU 726094 B2 AU726094 B2 AU 726094B2 AU 59862/98 A AU59862/98 A AU 59862/98A AU 5986298 A AU5986298 A AU 5986298A AU 726094 B2 AU726094 B2 AU 726094B2
Authority
AU
Australia
Prior art keywords
limonene
acetylsalicylic acid
transdermal therapeutic
dimethylisosorbide
therapeutic system
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU59862/98A
Other languages
English (en)
Other versions
AU5986298A (en
Inventor
Gerd Hoffmann
Michael Horstmann
Heinrich Kindel
Theresa Maria Murphy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LTS Lohmann Therapie Systeme AG
Original Assignee
LTS Lohmann Therapie Systeme AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LTS Lohmann Therapie Systeme AG filed Critical LTS Lohmann Therapie Systeme AG
Publication of AU5986298A publication Critical patent/AU5986298A/en
Application granted granted Critical
Publication of AU726094B2 publication Critical patent/AU726094B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7092—Transdermal patches having multiple drug layers or reservoirs, e.g. for obtaining a specific release pattern, or for combining different drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU59862/98A 1997-01-15 1998-01-03 Acetylsalicylic acid-containing transdermal therapeutic system with absorption enhancement Ceased AU726094B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19701059 1997-01-15
DE19701059A DE19701059C2 (de) 1997-01-15 1997-01-15 Acetylsalicylsäure enthaltendes transdermales therapeutisches System mit Resorptionsverstärkung
PCT/EP1998/000013 WO1998031348A1 (de) 1997-01-15 1998-01-03 Acetylsalicylsäure enthaltendes transdermales therapeutisches system mit resorptionsverstärkung

Publications (2)

Publication Number Publication Date
AU5986298A AU5986298A (en) 1998-08-07
AU726094B2 true AU726094B2 (en) 2000-11-02

Family

ID=7817375

Family Applications (1)

Application Number Title Priority Date Filing Date
AU59862/98A Ceased AU726094B2 (en) 1997-01-15 1998-01-03 Acetylsalicylic acid-containing transdermal therapeutic system with absorption enhancement

Country Status (8)

Country Link
EP (1) EP1023053A1 (ja)
JP (1) JP2001508069A (ja)
KR (1) KR20000070228A (ja)
AU (1) AU726094B2 (ja)
CA (1) CA2277366A1 (ja)
DE (1) DE19701059C2 (ja)
NO (1) NO993435L (ja)
WO (1) WO1998031348A1 (ja)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19949252B4 (de) * 1999-10-13 2004-02-12 Lts Lohmann Therapie-Systeme Ag Verwendung eines superfiziellen therapeutischen Systems zur topischen Applikation von Acetylsalicylsäure zur Behandlung von Akne-Erkrankungen und Verfahren zu seiner Herstellung
DE19949202A1 (de) * 1999-10-13 2001-05-03 Lohmann Therapie Syst Lts Transdermales therapeutisches System zur Abgabe von Acetylsalicylsäure und/oder Salicylsäure
DE19959913A1 (de) * 1999-12-11 2001-06-28 Lohmann Therapie Syst Lts Acetylsalicylsäure enthaltendes transdermales System zur Behandlung von Migräne
KR100448469B1 (ko) * 2001-10-26 2004-09-13 신풍제약주식회사 항염증제의 경피 조성물 및 장치
DE60227691D1 (de) 2001-11-01 2008-08-28 Nektar Therapeutics Sprühtrocknungsverfahren
DE10338162B3 (de) † 2003-08-20 2005-06-02 Haldex Brake Products Gmbh Verfahren zum Betreiben einer Druckluftbeschaffungsanlage eines Kraftfahrzeuges sowie Druckluftaufbereitungseinrichtung
DE102005033543A1 (de) * 2005-07-14 2007-01-18 Grünenthal GmbH Ein einen Duftstoff aufweisendes transdermales therapeutisches System
DE102005050431A1 (de) 2005-10-21 2007-04-26 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System zur Verabreicherung lipophiler und/oder wenig hautpermeabler Wirkstoffe
IT202000014578A1 (it) * 2020-06-18 2021-12-18 Poli Md S R L Dispositivo medicale comprendente acido acetil salicilico

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4228162A (en) * 1979-07-09 1980-10-14 Research Corporation Dimethyl isosorbide in liquid formulation of aspirin
US5164416A (en) * 1989-02-03 1992-11-17 Lintec Corporation Transdermal therapeutic formulation containing a limonene
DE4332093C2 (de) * 1993-09-22 1995-07-13 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit dem Wirkstoff Acetylsalicylsäure und Verfahren zu seiner Herstellung
DE4332094C2 (de) * 1993-09-22 1995-09-07 Lohmann Therapie Syst Lts Lösemittelfrei herstellbares Wirkstoffpflaster und Verfahren zu seiner Herstellung

Also Published As

Publication number Publication date
NO993435D0 (no) 1999-07-12
DE19701059C2 (de) 2000-12-21
AU5986298A (en) 1998-08-07
JP2001508069A (ja) 2001-06-19
EP1023053A1 (de) 2000-08-02
DE19701059A1 (de) 1998-07-16
NO993435L (no) 1999-07-12
KR20000070228A (ko) 2000-11-25
WO1998031348A1 (de) 1998-07-23
CA2277366A1 (en) 1998-07-23

Similar Documents

Publication Publication Date Title
DE4020144C2 (ja)
EP1312360A1 (en) Analgesic/antiinflammatory patches for topical use
JP2638635B2 (ja) 経皮吸収製剤
JPH09503755A (ja) 活性物質としてアセチルサリチル酸を用いる経皮吸収治療システム
AU726094B2 (en) Acetylsalicylic acid-containing transdermal therapeutic system with absorption enhancement
CA2200189C (en) Scopolamine plaster
JPS6049601B2 (ja) 治療デバイス
CN112689505B (zh) 含水贴剂
MXPA01000126A (es) Compuesto que contiene por lo menos un principio activo que incide en el indice de grasa en la sangre.
CA2849956A1 (en) Plaster having adjustable occlusion
JP5410071B2 (ja) エステル化抑制剤及びエステル化抑制方法
JPS632533B2 (ja)
JP2869167B2 (ja) 徐放性貼付製剤
JP4943643B2 (ja) 経皮吸収製剤
US5705185A (en) Transdermal delivery of estradiol and process for manufacturing said device
JP2006022057A (ja) 経皮吸収製剤用基剤およびこれを用いた皮膚貼付製剤
JPS5835112A (ja) 複合製剤
JPH0413617A (ja) 貼付剤
JPH01233212A (ja) 貼付剤
SK22097A3 (en) Transdermal therapeutic system and a method for producing same
JP4584620B2 (ja) 消炎鎮痛外用剤
JP4988080B2 (ja) 経皮吸収型製剤
JPS63246326A (ja) ニトログリセリンを含有する感圧性粘着テープまたはシートの製造方法
JPS5835113A (ja) 複合製剤
US5965155A (en) Transdermal therapeutic system with pentylene tetrazol as active substance

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired